Conferenceseries LLC LTD – Immunology

Sessions/Tracks

Conference Series LLC LTDinvites participants from all over the world to attend "11thWorld Congress and Expo on Immunology" July 24 25, 2019 Vancouver, Canada includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Presenters can availup to 20 CME credits..

The annualInternational Conference on Immunologyoffer a unique platform for academia, Societies and Industries interested in immunology and Biomedical sciences to share the latest trends and important issues in the field. Immunology Summit-2019 brings together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. TheImmunology Conferencehosting presentations from editors of prominent refereed journals, renowned and active investigators and decision makers in the field ofImmunology. Immunology Summit 2019 Organizing Committee also intended to encourage Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.

Track 1:ClinicalImmunology: Current & Future Research

Immunology is the study of the immune system. The immune system is how all animals, including humans, protect themselves against diseases. The study of diseases caused by disorders of the immune system is clinical immunology. The disorders of the immune system fall into two broad categories:

Immunodeficiency, in this immune system fails to provide an adequate response.

Autoimmunity, in this immune system attacks its own host's body.

Related:Immunology Conferences|Immunologists Meetings|Conference Series LLC Ltd

9thEuropean Immunology Conference, June 14-16, 2018 Rome, Italy; 10thWorld Congress and Expo onImmunologyOctober 19-20, 2018 New York, USA; 5thInternationalConference on Parasitology, July 12-13, 2018 Paris, France; 10thInternational Conference onClinical Immunology andCellular Immunology, August 6-7, 2018 Madrid, Spain; AnnualCongress onImmunology&Immunotechnology, September 13-14, 2018 Zurich, Switzerland; 3rdInternationalConference onTumor&CancerImmunologyandImmunotherapy; September 17-18, 2018 San Diego, USA; 5thEuropean Congress of Immunology, September 2-5, 2018, Amsterdam, Netherlands; 29thAnnual Conference of theAustralasian Society ofClinical ImmunologyandAllergy, September 4-8, 2018, Canberra, Australia; 12thInternationalConference on Allergy, Asthma &Clinical Immunology, October 1-2, 2018 Moscow, Russia; 3rdInternationalConference on Autoimmunity, November 26-27, 2018 Dublin, Ireland; 3rdAntibodies and Bio Therapeutics Congress& B2B, November 08-09, 2017 Las Vegas, Nevada, USA

Track 2:Cancer and Tumor Immunobiology

The immune system is the bodys first line of defence against most diseases and unnatural invaders.Cancer Immunobiologyis a branch ofimmunologyand it studies interactions between theimmune systemandcancer cells. These cancer cells, through subtle alterations, become immortal malignant cells but are often not changed enough to elicit an immune reaction.Understanding how the immune system worksor does not workagainst cancer is a primary focus of Cancer Immunology investigators. Certain cells of the immune system, including natural killer cells, dendritic cells (DCs) and effector T cells, are capable of driving potent anti-tumour responses.

Tumor Immunobiology

The immune system can promote the elimination of tumours, but often immune responses are modulated or suppressed by the tumour microenvironment. TheTumour microenvironmentis an important aspect of cancer biology that contributes to tumour initiation, tumour progression and responses to therapy. Cells and molecules of the immune system are a fundamental component of the tumour microenvironment. Importantly, therapeutic strategies can harness the immune system to specifically target tumour cells and this is particularly appealing owing to the possibility of inducing tumour-specific immunological memory, which might cause long-lasting regression and prevent relapse in cancer patients. The composition and characteristics of the tumour micro environment vary widely and are important in determining the anti-tumour immune response. Tumour cells often induce an immunosuppressive microenvironment, which favours the development of immuno suppressive populations of immune cells, such as myeloid-derived suppressor cells and regulatory T cells.

Related:Immunology Conferences|Immunologists Meetings|Conference Series LLC Ltd

9thEuropean Immunology Conference, June 14-16, 2018 Rome, Italy; 10thWorld Congress and Expo onImmunologyOctober 19-20, 2018 New York, USA; 5thInternationalConference on Parasitology, July 12-13, 2018 Paris, France; 10thInternational Conference onClinical Immunology andCellular Immunology, August 6-7, 2018 Madrid, Spain; AnnualCongress onImmunology&Immunotechnology, September 13-14, 2018 Zurich, Switzerland; 3rdInternationalConference onTumor&CancerImmunologyandImmunotherapy; September 17-18, 2018 San Diego, USA; 5thEuropean Congress of Immunology, September 2-5, 2018, Amsterdam, Netherlands; 29thAnnual Conference of theAustralasian Society ofClinical ImmunologyandAllergy, September 4-8, 2018, Canberra, Australia; 12thInternationalConference on Allergy, Asthma &Clinical Immunology, October 1-2, 2018 Moscow, Russia; 3rdInternationalConference on Autoimmunity, November 26-27, 2018 Dublin, Ireland; 3rdAntibodies and Bio Therapeutics Congress& B2B, November 08-09, 2017 Las Vegas, Nevada, USA

Track 3:Inflammation and Therapies

Inflammation is the body's attempt at self-protection; the aim being to remove harmful stimuli, including damaged cells, irritants, or pathogens - and begin the healing process. In Inflammation the body's whiteblood cellsand substances they produce protect us from infection with foreign organisms, such as bacteria and viruses. However, in some diseases, likearthritis, the body's defense system, the immune system triggers an inflammatory response when there are no foreign invaders to fight off. In these diseases, called autoimmune diseases, the body's normally protective immune system causes damage to its own tissues. The body responds as if normal tissues are infected or somehow abnormal. Inflammation involves immune cells, blood vessels, and molecular mediators. The purpose of inflammation is to eliminate the initial cause of cell injury, clear out necrotic cells and tissues damaged from the original insult and the inflammatory process, and to initiate tissue repair. signs of acute inflammation are pain, heat, redness, swelling, and loss of function

Therapies

Inflammation Therapy is a treatment for chronic disease involving a combination of lifestyle factors and medications designed to enable the immune system to fight the disease. Techniques used include heat therapy, cold therapy, electrical stimulation, traction, massage, and acupuncture. Heat increases blood flow and makes connective tissue more flexible. It temporarily decreases joint stiffness, pain, and muscle spasms. Heat also helps reduce inflammation and the buildup of fluid in tissues (edema). Heat therapy is used to treat inflammation (including various forms of arthritis), muscle spasm, and injuries such as sprains and strains. Cold therapy Applying cold may help numb tissues and relieve muscle spasms, pain due to injuries, and low back pain or inflammation that has recently developed. Cold may be applied using an ice bag, a cold pack, or fluids (such as ethyl chloride) that cool by evaporation. The therapist limits the time and amount of cold exposure to avoid damaging tissues and reducing body temperature (causing hypothermia). Cold is not applied to tissues with a reduced blood supply (for example, when the arteries are narrowed by peripheral arterial disease).

Related:Immunology Conferences|Immunologists Meetings|Conference Series LLC Ltd

9thEuropean Immunology Conference, June 14-16, 2018 Rome, Italy; 10thWorld Congress and Expo onImmunologyOctober 19-20, 2018 New York, USA; 5thInternationalConference on Parasitology, July 12-13, 2018 Paris, France; 10thInternational Conference onClinical Immunology andCellular Immunology, August 6-7, 2018 Madrid, Spain; AnnualCongress onImmunology&Immunotechnology, September 13-14, 2018 Zurich, Switzerland; 3rdInternationalConference onTumor&CancerImmunologyandImmunotherapy; September 17-18, 2018 San Diego, USA; 5thEuropean Congress of Immunology, September 2-5, 2018, Amsterdam, Netherlands; 29thAnnual Conference of theAustralasian Society ofClinical ImmunologyandAllergy, September 4-8, 2018, Canberra, Australia; 12thInternationalConference on Allergy, Asthma &Clinical Immunology, October 1-2, 2018 Moscow, Russia; 3rdInternationalConference on Autoimmunity, November 26-27, 2018 Dublin, Ireland; 3rdAntibodies and Bio Therapeutics Congress& B2B, November 08-09, 2017 Las Vegas, Nevada, USA

Track 4:Molecular and Structural Immunology

Molecular Immunology

Molecular immunology deals with immune responses at cellular and molecular level. Molecular immunology has been evolved for better understanding of the sub-cellular immune responses for prevention and treatment of immune related disorders and immune deficient diseases. Journal of molecular immunology focuses on the invitro and invivo immunological responses of the host. Molecular Immunology focuses on the areas such as immunological disorders, invitro and invivo immunological host responses, humoral responses, immunotherapies for treatment of cancer, treatment of autoimmune diseases such as Hashimotos disease, myasthenia gravis, rheumatoid arthritis and systemic lupus erythematosus. Treatment of Immune deficiencies such as hypersensitivities, chronic granulomatous disease, diagnostic immunology research aspects, allografts, etc..

Structural Immunology

Host immune system is an important and sophisticated system, maintaining the balance of host response to "foreign" antigens and ignorance to the normal-self. To fulfill this achievement the system manipulates a cell-cell interaction through appropriate interactions between cell-surface receptors and cell-surface ligands, or cell-secreted soluble effector molecules to their ligands/receptors/counter-receptors on the cell surface, triggering further downstream signaling for response effects. T cells and NK cells are important components of the immune system for defending the infections and malignancies and maintaining the proper response against over-reaction to the host. Receptors on the surface of T cells and NK cells include a number of important protein molecules, for example, T cell receptor (TCR), co-receptor CD8 or CD4, co-stimulator CD28, CTLA4, KIR, CD94/NKG2, LILR (ILT/LIR/CD85), Ly49, and so forth.

Related:Immunology Conferences|Immunologists Meetings|Conference Series LLC Ltd

9thEuropean Immunology Conference, June 14-16, 2018 Rome, Italy; 10thWorld Congress and Expo onImmunologyOctober 19-20, 2018 New York, USA; 5thInternationalConference on Parasitology, July 12-13, 2018 Paris, France; 10thInternational Conference onClinical Immunology andCellular Immunology, August 6-7, 2018 Madrid, Spain; AnnualCongress onImmunology&Immunotechnology, September 13-14, 2018 Zurich, Switzerland; 3rdInternationalConference onTumor&CancerImmunologyandImmunotherapy; September 17-18, 2018 San Diego, USA; 5thEuropean Congress of Immunology, September 2-5, 2018, Amsterdam, Netherlands; 29thAnnual Conference of theAustralasian Society ofClinical ImmunologyandAllergy, September 4-8, 2018, Canberra, Australia; 12thInternationalConference on Allergy, Asthma &Clinical Immunology, October 1-2, 2018 Moscow, Russia; 3rdInternationalConference on Autoimmunity, November 26-27, 2018 Dublin, Ireland; 3rdAntibodies and Bio Therapeutics Congress& B2B, November 08-09, 2017 Las Vegas, Nevada, USA

Track 5:Transplantation Immunology

Transplantation is an act of transferring cells, tissues, or organ from one site to other. Graft is implanted cell, tissue or organ. Development of the field of organ and tissue transplantation has accelerated remarkably since thehuman major histocompatibility complex(mhc) was discovered in 1967. Matching of donor and recipient for mhc antigens has been shown to have a significant positive effect on graft acceptance. The roles of the different components of the immune system involved in the tolerance or rejection of grafts and in graft-versus-host disease have been clarified. These components include: antibodies, antigen presenting cells, helper and cytotoxic t cell subsets, immune cell surface molecules, signaling mechanisms and cytokines that they release. The development of pharmacologic and biological agents that interfere with the alloimmune response and graft rejection has had a crucial role in the success of organ transplantation. Combinations of these agents work synergistically, leading to lower doses of immunosuppressive drugs and reduced toxicity. Significant numbers of successful solid organ transplants include those of the kidneys, liver, heart and lung.

Related:Immunology Conferences|Immunologists Meetings|Conference Series LLC Ltd

9thEuropean Immunology Conference, June 14-16, 2018 Rome, Italy; 10thWorld Congress and Expo onImmunologyOctober 19-20, 2018 New York, USA; 5thInternationalConference on Parasitology, July 12-13, 2018 Paris, France; 10thInternational Conference onClinical Immunology andCellular Immunology, August 6-7, 2018 Madrid, Spain; AnnualCongress onImmunology&Immunotechnology, September 13-14, 2018 Zurich, Switzerland; 3rdInternationalConference onTumor&CancerImmunologyandImmunotherapy; September 17-18, 2018 San Diego, USA; 5thEuropean Congress of Immunology, September 2-5, 2018, Amsterdam, Netherlands; 29thAnnual Conference of theAustralasian Society ofClinical ImmunologyandAllergy, September 4-8, 2018, Canberra, Australia; 12thInternationalConference on Allergy, Asthma &Clinical Immunology, October 1-2, 2018 Moscow, Russia; 3rdInternationalConference on Autoimmunity, November 26-27, 2018 Dublin, Ireland; 3rdAntibodies and Bio Therapeutics Congress& B2B, November 08-09, 2017 Las Vegas, Nevada, USA

Track 6:Infectious Diseases,Emerging and Reemerging diseases: Confronting Future Outbreaks

Infectious diseasesare disorders caused by organisms such as bacteria, viruses,fungior parasites. Many organisms live in and on our bodies. They're normally harmless or even helpful, but under certain conditions, some organisms may causedisease.Someinfectious diseasescan be passed from person to person. Many infectious diseases, such asmeaslesand chickenpox, can be prevented by vaccines. Frequent and thorough hand-washing also helps protect you from infectious diseases.

There are four main kinds of germs:

Bacteria - one-celled germs that multiply quickly and may release chemicals which can make you sick

Viruses- capsules that contain genetic material, and use your own cells to multiply

Fungi - primitive plants, like mushrooms or mildew

Related:Immunology Conferences|Immunologists Meetings|Conference Series LLC Ltd

9thEuropean Immunology Conference, June 14-16, 2018 Rome, Italy; 10thWorld Congress and Expo onImmunologyOctober 19-20, 2018 New York, USA; 5thInternationalConference on Parasitology, July 12-13, 2018 Paris, France; 10thInternational Conference onClinical Immunology andCellular Immunology, August 6-7, 2018 Madrid, Spain; AnnualCongress onImmunology&Immunotechnology, September 13-14, 2018 Zurich, Switzerland; 3rdInternationalConference onTumor&CancerImmunologyandImmunotherapy; September 17-18, 2018 San Diego, USA; 5thEuropean Congress of Immunology, September 2-5, 2018, Amsterdam, Netherlands; 29thAnnual Conference of theAustralasian Society ofClinical ImmunologyandAllergy, September 4-8, 2018, Canberra, Australia; 12thInternationalConference on Allergy, Asthma &Clinical Immunology, October 1-2, 2018 Moscow, Russia; 3rdInternationalConference on Autoimmunity, November 26-27, 2018 Dublin, Ireland; 3rdAntibodies and Bio Therapeutics Congress& B2B, November 08-09, 2017 Las Vegas, Nevada, USA

Track 7:Autoimmune Diseases

An autoimmune disease develops when your immune system, which defends your body against disease, decides your healthy cells are foreign. As a result, your immune system attacks healthy cells. An autoimmune disorder may result in the destruction of body tissue, abnormal growth of an organ, Changes in organ function. Depending on the type, an autoimmune disease can affect one or many different types of body tissue. Areas often affected by autoimmune disorders include Blood vessels, Connective tissues, Endocrineglands such as the thyroid or pancreas, Joints Muscles, Red blood cells, Skin It can also cause abnormal organ growth and changes in organ function. There are as many as 80 types of autoimmune diseases. Many of them have similar symptoms, which makes them very difficult to diagnose. Its also possible to have more than one at the same time. Common autoimmune disorders include Addison's disease, Dermatomyositis, Graves' disease, Hashimoto's thyroiditis, Multiple sclerosis, Myasthenia gravis, Pernicious anemia, Reactive arthritis. Autoimmune diseases usually fluctuate between periods of remission (little or no symptoms) and flare-ups (worsening symptoms). Currently, treatment for autoimmune diseases focuses on relieving symptoms because there is no curative therapy.

Related:Immunology Conferences|Immunologists Meetings|Conference Series LLC Ltd

9thEuropean Immunology Conference, June 14-16, 2018 Rome, Italy; 10thWorld Congress and Expo onImmunologyOctober 19-20, 2018 New York, USA; 5thInternationalConference on Parasitology, July 12-13, 2018 Paris, France; 10thInternational Conference onClinical Immunology andCellular Immunology, August 6-7, 2018 Madrid, Spain; AnnualCongress onImmunology&Immunotechnology, September 13-14, 2018 Zurich, Switzerland; 3rdInternationalConference onTumor&CancerImmunologyandImmunotherapy; September 17-18, 2018 San Diego, USA; 5thEuropean Congress of Immunology, September 2-5, 2018, Amsterdam, Netherlands; 29thAnnual Conference of theAustralasian Society ofClinical ImmunologyandAllergy, September 4-8, 2018, Canberra, Australia; 12thInternationalConference on Allergy, Asthma &Clinical Immunology, October 1-2, 2018 Moscow, Russia; 3rdInternationalConference on Autoimmunity, November 26-27, 2018 Dublin, Ireland; 3rdAntibodies and Bio Therapeutics Congress& B2B, November 08-09, 2017 Las Vegas, Nevada, USA

Track 8:Viral Immunology: Emerging and Re-emerging Diseases

Immunology is the study of all aspects of the immune system in all organisms. It deals with the physiological functioning of the immune system in states of both health and disease; malfunctions of the immune system in immunological disorders (autoimmune diseases, hypersensitivities, immune deficiency, transplant rejection); the physical, chemical and physiological characteristics of the components of the immune system in vitro, in situ, and in vivo.

Viruses are strongly immunogenic and induces 2 types of immune responses; humoral and cellular. The repertoire of specificities of T and B cells are formed by rearrangements and somatic mutations. T and B cells do not generally recognize the same epitopes present on the same virus. B cells see the free unaltered proteins in their native 3-D conformation whereas T cells usually see the Ag in a denatured form in conjunction with MHC molecules. The characteristics of the immune reaction to the same virus may differ in different individuals depending on their genetic constitutions.

Related:Immunology Conferences|Immunologists Meetings|Conference Series LLC Ltd

9thEuropean Immunology Conference, June 14-16, 2018 Rome, Italy; 10thWorld Congress and Expo onImmunologyOctober 19-20, 2018 New York, USA; 5thInternationalConference on Parasitology, July 12-13, 2018 Paris, France; 10thInternational Conference onClinical Immunology andCellular Immunology, August 6-7, 2018 Madrid, Spain; AnnualCongress onImmunology&Immunotechnology, September 13-14, 2018 Zurich, Switzerland; 3rdInternationalConference onTumor&CancerImmunologyandImmunotherapy; September 17-18, 2018 San Diego, USA; 5thEuropean Congress of Immunology, September 2-5, 2018, Amsterdam, Netherlands; 29thAnnual Conference of theAustralasian Society ofClinical ImmunologyandAllergy, September 4-8, 2018, Canberra, Australia; 12thInternationalConference on Allergy, Asthma &Clinical Immunology, October 1-2, 2018 Moscow, Russia; 3rdInternationalConference on Autoimmunity, November 26-27, 2018 Dublin, Ireland; 3rdAntibodies and Bio Therapeutics Congress& B2B, November 08-09, 2017 Las Vegas, Nevada, USA

Track 9:Pediatric Immunology

A child suffering from allergies or other problems with his immune system is referred as pediatric immunology. Childs immune system fights against infections. If the child has allergies, their immune system wrongly reacts to things that are usually harmless. Pet dander, pollen, dust, mold spores, insect stings, food, and medications are examples of such things. This reaction may cause their body to respond with health problems such as asthma, hay fever, hives, eczema (a rash), or a very severe and unusual reaction calledanaphylaxis. Sometimes, if your childs immune system is not working right, he may suffer from frequent, severe, and/or uncommon infections. Examples of such infections are sinusitis (inflammation of one or more of the sinuses), pneumonia (infection of the lung), thrush (a fungus infection in the mouth), and abscesses (collections of pus surrounded by inflamed tissue) that keep coming back.

Related:Immunology Conferences|Immunologists Meetings|Conference Series LLC Ltd

9thEuropean Immunology Conference, June 14-16, 2018 Rome, Italy; 10thWorld Congress and Expo onImmunologyOctober 19-20, 2018 New York, USA; 5thInternationalConference on Parasitology, July 12-13, 2018 Paris, France; 10thInternational Conference onClinical Immunology andCellular Immunology, August 6-7, 2018 Madrid, Spain; AnnualCongress onImmunology&Immunotechnology, September 13-14, 2018 Zurich, Switzerland; 3rdInternationalConference onTumor&CancerImmunologyandImmunotherapy; September 17-18, 2018 San Diego, USA; 5thEuropean Congress of Immunology, September 2-5, 2018, Amsterdam, Netherlands; 29thAnnual Conference of theAustralasian Society ofClinical ImmunologyandAllergy, September 4-8, 2018, Canberra, Australia; 12thInternationalConference on Allergy, Asthma &Clinical Immunology, October 1-2, 2018 Moscow, Russia; 3rdInternationalConference on Autoimmunity, November 26-27, 2018 Dublin, Ireland; 3rdAntibodies and Bio Therapeutics Congress& B2B, November 08-09, 2017 Las Vegas, Nevada, USA

Track 10:Immunotherapy & Cancer Immunotherapy: From Basic Biology to Translational Research

Immunotherapy is treatment that uses certain parts of a persons immune system to fight diseases such as cancer. This can be done in a couple of ways:

Stimulating your own immune system to work harder or smarter to attack cancer cells Giving you immune system components, such as man-made immune system proteins

Some types of immunotherapy are also sometimes called biologic therapy or biotherapy. In the last few decades immunotherapy has become an important part of treating some types of cancer. Newer types of immune treatments are now being studied, and theyll impact how we treat cancer in the future. Immunotherapy includes treatments that work in different ways. Some boost the bodys immune system in a very general way. Others help train the immune system to attack cancer cells specifically.

Cancer immunotherapyis the use of the immune system to treat cancer. The main types of immunotherapy now being used to treat cancer include:

Monoclonal antibodies: these are man-made versions of immune system proteins. Antibodies can be very useful in treating cancer because they can be designed to attack a very specific part of a cancer cell.

Immune checkpoint inhibitors: these drugs basically take the brakes off the immune system, which helps it recognize and attack cancer cells.

Cancer vaccines: vaccines are substances put into the body to start an immune response against certain diseases. We usually think of them as being given to healthy people to help prevent infections. But some vaccines can help prevent or treat cancer.

Other, non-specific immunotherapies: these treatments boost the immune system in a general way, but this can still help the immune system attack cancer cells.

Immunotherapy drugsare now used to treat many different types of cancer. For more information about immunotherapy as a treatment for a specific cancer, please see our information on that type of cancer.

Related:Immunology Conferences|Immunologists Meetings|Conference Series LLC Ltd

9thEuropean Immunology Conference, June 14-16, 2018 Rome, Italy; 10thWorld Congress and Expo onImmunologyOctober 19-20, 2018 New York, USA; 5thInternationalConference on Parasitology, July 12-13, 2018 Paris, France; 10thInternational Conference onClinical Immunology andCellular Immunology, August 6-7, 2018 Madrid, Spain; AnnualCongress onImmunology&Immunotechnology, September 13-14, 2018 Zurich, Switzerland; 3rdInternationalConference onTumor&CancerImmunologyandImmunotherapy; September 17-18, 2018 San Diego, USA; 5thEuropean Congress of Immunology, September 2-5, 2018, Amsterdam, Netherlands; 29thAnnual Conference of theAustralasian Society ofClinical ImmunologyandAllergy, September 4-8, 2018, Canberra, Australia; 12thInternationalConference on Allergy, Asthma &Clinical Immunology, October 1-2, 2018 Moscow, Russia; 3rdInternationalConference on Autoimmunity, November 26-27, 2018 Dublin, Ireland; 3rdAntibodies and Bio Therapeutics Congress& B2B, November 08-09, 2017 Las Vegas, Nevada, USA

Track 11:Immunology and Diabetes

Immunologyis the study of the immune system, which is responsible for protecting the body from foreign cells such as viruses, bacteria and parasites. Immune system cells called T and B lymphocytes identify and destroy these invaders. Thelymphocytesusually recognize and ignore the bodys own tissue (a condition called immunological self-tolerance), but certain autoimmune disorders trigger a malfunction in the immune response causing an attack on the bodys own cells due to a loss ofimmune tolerance.

Type 1 diabetes is anautoimmune diseasethat occurs when the immune system mistakenly attacks insulin-producing islet cells in the pancreas. This attack begins years before type 1 diabetes becomes evident, so by the time someone is diagnosed, extensive damage has already been done and the ability to produceinsulinis lost.

Related:Immunology Conferences|Immunologists Meetings|Conference Series LLC Ltd

9thEuropean Immunology Conference, June 14-16, 2018 Rome, Italy; 10thWorld Congress and Expo onImmunologyOctober 19-20, 2018 New York, USA; 5thInternationalConference on Parasitology, July 12-13, 2018 Paris, France; 10thInternational Conference onClinical Immunology andCellular Immunology, August 6-7, 2018 Madrid, Spain; AnnualCongress onImmunology&Immunotechnology, September 13-14, 2018 Zurich, Switzerland; 3rdInternationalConference onTumor&CancerImmunologyandImmunotherapy; September 17-18, 2018 San Diego, USA; 5thEuropean Congress of Immunology, September 2-5, 2018, Amsterdam, Netherlands; 29thAnnual Conference of theAustralasian Society ofClinical ImmunologyandAllergy, September 4-8, 2018, Canberra, Australia; 12thInternationalConference on Allergy, Asthma &Clinical Immunology, October 1-2, 2018 Moscow, Russia; 3rdInternationalConference on Autoimmunity, November 26-27, 2018 Dublin, Ireland; 3rdAntibodies and Bio Therapeutics Congress& B2B, November 08-09, 2017 Las Vegas, Nevada, USA

Track 12:Immune Tolerance

Immunological toleranceis the failure to mount animmuneresponse to an antigen. It can be: Natural or "self"tolerance. This is the failure (a good thing) to attack the body's own proteins and other antigens. If the immunesystem should respond to "self",an autoimmune diseasemay result. Natural or "self" tolerance: Induced tolerance: This is tolerance to externalantigens that has been created by deliberately manipulating theimmune system.

Related:Immunology Conferences|Immunologists Meetings|Conference Series LLC Ltd

9thEuropean Immunology Conference, June 14-16, 2018 Rome, Italy; 10thWorld Congress and Expo onImmunologyOctober 19-20, 2018 New York, USA; 5thInternationalConference on Parasitology, July 12-13, 2018 Paris, France; 10thInternational Conference onClinical Immunology andCellular Immunology, August 6-7, 2018 Madrid, Spain; AnnualCongress onImmunology&Immunotechnology, September 13-14, 2018 Zurich, Switzerland; 3rdInternationalConference onTumor&CancerImmunologyandImmunotherapy; September 17-18, 2018 San Diego, USA; 5thEuropean Congress of Immunology, September 2-5, 2018, Amsterdam, Netherlands; 29thAnnual Conference of theAustralasian Society ofClinical ImmunologyandAllergy, September 4-8, 2018, Canberra, Australia; 12thInternationalConference on Allergy, Asthma &Clinical Immunology, October 1-2, 2018 Moscow, Russia; 3rdInternationalConference on Autoimmunity, November 26-27, 2018 Dublin, Ireland; 3rdAntibodies and Bio Therapeutics Congress& B2B, November 08-09, 2017 Las Vegas, Nevada, USA

Track 13:Vaccines and Immunotherapy

Vaccine is a biological preparation that improves immunity to particular disease. It contains certain agent that not only resembles a disease causing microorganism but it also stimulates bodys immune system to recognise the foreign agents. Vaccines are dead or inactivated organisms or purified products derived from them. whole organism vaccines purified macromolecules as vaccines,recombinant vaccines, DNA vaccines. The immune system recognizes vaccine agents as foreign, destroys them, and "remembers" them. The administration of vaccines is called vaccination. In order to provide best protection, children are recommended to receive vaccinations as soon as their immune systems are sufficiently developed to respond to particular vaccines with additional "booster" shots often required to achieve "full immunity".

Immunotherapy is treatment that uses certain parts of a persons immune system to fight diseases such as cancer. This can be done in a couple of ways:

Stimulating your own immune system to work harder or smarter to attack cancer cells

Giving you immune system components, such as man-made immune system proteins

Some types of immunotherapy are also sometimes called biologic therapy or biotherapy. In the last few decades immunotherapy has become an important part of treating some types of cancer. Newer types of immune treatments are now being studied, and theyll impact how we treat cancer in the future. Immunotherapy includes treatments that work in different ways. Some boost the bodys immune system in a very general way. Others help train the immune system to attack cancer cells specifically. Immunotherapy works better for some types of cancer than for others. Its used by itself for some of these cancers, but for others it seems to work better when used with other types of treatment.

Related:Immunology Conferences|Immunologists Meetings|Conference Series LLC Ltd

9thEuropean Immunology Conference, June 14-16, 2018 Rome, Italy; 10thWorld Congress and Expo onImmunologyOctober 19-20, 2018 New York, USA; 5thInternationalConference on Parasitology, July 12-13, 2018 Paris, France; 10thInternational Conference onClinical Immunology andCellular Immunology, August 6-7, 2018 Madrid, Spain; AnnualCongress onImmunology&Immunotechnology, September 13-14, 2018 Zurich, Switzerland; 3rdInternationalConference onTumor&CancerImmunologyandImmunotherapy; September 17-18, 2018 San Diego, USA; 5thEuropean Congress of Immunology, September 2-5, 2018, Amsterdam, Netherlands; 29thAnnual Conference of theAustralasian Society ofClinical ImmunologyandAllergy, September 4-8, 2018, Canberra, Australia; 12thInternationalConference on Allergy, Asthma &Clinical Immunology, October 1-2, 2018 Moscow, Russia; 3rdInternationalConference on Autoimmunity, November 26-27, 2018 Dublin, Ireland; 3rdAntibodies and Bio Therapeutics Congress& B2B, November 08-09, 2017 Las Vegas, Nevada, USA

Track 14:Immunologic Techniques, Microbial Control and Therapeutics

Immunological techniques include both experimental methods to study the immune system and methods to generate or use immunological reagents as experimental tools. The most common immunological methods relate to the production and use of antibodies to detect specific proteins in biological samples. Various laboratory techniques exist that rely on the use of antibodies to visualize components of microorganisms or other cell types and to distinguish one cell or organism type from another. Immunologic techniques are used for: Quantitating and detectingantibodiesand/orantigens, Purifying immunoglobulins, lymphokines and other molecules of the immune system, Isolating antigens and other substances important in immunological processes, Labelling antigens and antibodies, Localizing antigens and/or antibodies in tissues and cells, Detecting, and fractionatingimmunocompetent cells, Assaying forcellular immunity, Documenting cell-cell interactions, Initiating immunity and unresponsiveness, Transplantingtissues, Studying items closely related to immunity such as complement,reticuloendothelial systemand others, Molecular techniques for studying immune cells and theirreceptors, Imaging of the immune system, Methods for production or their fragments ineukaryoticandprokaryotic cells.

Microbial control:

Control of microbial growth, as used here, means to inhibit or prevent growth of microorganisms. This control is achieved in two basic ways: (1) by killing microorganisms or (2) by inhibiting the growth of microorganisms. Control of growth usually involves the use of physical or chemical agents which either kill or prevent the growth of microorganisms. Agents which kill cells are called cidal agents; agents which inhibit the growth of cells (without killing them) are referred to as static agents. Thus, the term bactericidal refers to killing bacteria, and bacteriostatic refers to inhibiting the growth of bacterial cells. A bactericide kills bacteria, a fungicide kills fungi, and so on. In microbiology, sterilization refers to the complete destruction or elimination of all viable organisms in or on a substance being sterilized. There are no degrees of sterilization: an object or substance is either sterile or not. Sterilization procedures involve the use of heat, radiation or chemicals, or physical removal of cells.

Related:Immunology Conferences|Immunologists Meetings|Conference Series LLC Ltd

9thEuropean Immunology Conference, June 14-16, 2018 Rome, Italy; 10thWorld Congress and Expo onImmunologyOctober 19-20, 2018 New York, USA; 5thInternationalConference on Parasitology, July 12-13, 2018 Paris, France; 10thInternational Conference onClinical Immunology andCellular Immunology, August 6-7, 2018 Madrid, Spain; AnnualCongress onImmunology&Immunotechnology, September 13-14, 2018 Zurich, Switzerland; 3rdInternationalConference onTumor&CancerImmunologyandImmunotherapy; September 17-18, 2018 San Diego, USA; 5thEuropean Congress of Immunology, September 2-5, 2018, Amsterdam, Netherlands; 29thAnnual Conference of theAustralasian Society ofClinical ImmunologyandAllergy, September 4-8, 2018, Canberra, Australia; 12thInternationalConference on Allergy, Asthma &Clinical Immunology, October 1-2, 2018 Moscow, Russia; 3rdInternationalConference on Autoimmunity, November 26-27, 2018 Dublin, Ireland; 3rdAntibodies and Bio Therapeutics Congress& B2B, November 08-09, 2017 Las Vegas, Nevada, USA

Track 15:Immunodeficiency

Immunodeficiency is a state in which theimmune system's ability to fightinfectious diseaseis compromised or entirely absent. Immunodeficiency disorders prevent your body from adequately fighting infections and diseases. An immunodeficiency disorder also makes it easier for you to catch viruses and bacterial infections in the first place. Immunodeficiency disorders are often categorized as either congenital or acquired. A congenital, or primary, disorder is one you were born with. Acquired, or secondary, disorders are disorders you get later in life. Acquired disorders are more common thancongenital disorders. Immune system includes the following organs: spleen, tonsils, bone marrow, lymph nodes. These organs make and release lymphocytes. Lymphocytes are white blood cells classified as B cells and T cells. B and T cells fight invaders called antigens. B cells release antibodies specific to the disease your body detects. T cells kill off cells that are under attack by disease. An immunodeficiency disorder disrupts your bodys ability to defend itself against these antigens. Types of immunodeficiency disorder are Primary immunodeficiency disorders & Secondary immunodeficiency disorders.

Primary immunodeficiency disorders are immune disorders you are born with. Primary disorders include:

X-linked agammaglobulinemia (XLA)

Common variable immunodeficiency (CVID)

Severe combined immunodeficiency(SCID)

Secondary disorders happen when an outside source, such as a toxic chemical or infection, attacks your body. Severe burns and radiation also can cause secondary disorders.

Secondary disorders include: AIDS, cancers of the immune system such as leukemia, immune-complex diseases such as viral hepatitis, multiple myeloma.

Related:Immunology Conferences|Immunologists Meetings|Conference Series LLC Ltd

9thEuropean Immunology Conference, June 14-16, 2018 Rome, Italy; 10thWorld Congress and Expo onImmunologyOctober 19-20, 2018 New York, USA; 5thInternationalConference on Parasitology, July 12-13, 2018 Paris, France; 10thInternational Conference onClinical Immunology andCellular Immunology, August 6-7, 2018 Madrid, Spain; AnnualCongress onImmunology&Immunotechnology, September 13-14, 2018 Zurich, Switzerland; 3rdInternationalConference onTumor&CancerImmunologyandImmunotherapy; September 17-18, 2018 San Diego, USA; 5thEuropean Congress of Immunology, September 2-5, 2018, Amsterdam, Netherlands; 29thAnnual Conference of theAustralasian Society ofClinical ImmunologyandAllergy, September 4-8, 2018, Canberra, Australia; 12thInternationalConference on Allergy, Asthma &Clinical Immunology, October 1-2, 2018 Moscow, Russia; 3rdInternationalConference on Autoimmunity, November 26-27, 2018 Dublin, Ireland; 3rdAntibodies and Bio Therapeutics Congress& B2B, November 08-09, 2017 Las Vegas, Nevada, USA

The rest is here:
Conferenceseries LLC LTD - Immunology

Related Posts